Jeanne began her nursing career in 2016 after working in teaching and social work. Over the past eight years, she has worked full-time in dialysis, earning her BSN, MSN in Nursing Leadership and Management, and Certified Dialysis Nurse credential. For the last 4.5 years, Jeanne has served as Clinical Educator for the Sanford Dialysis Enterprise and co-chairs the Dialysis Policy and Procedure Committee. She leads staff education and develops policies, procedures, and audit tools to support dialysis operations across the Sanford Enterprise.

Naomi began her nursing career in 1995 after graduating with a bachelor of arts in nursing from Concordia College in Moorhead, Minnesota. She started her dialysis career in November of 2001 working in the Hemodialysis unit in Detroit Lakes, MN. Now, with almost 24 years of dialysis experience, her career has included in-center hemodialysis, 10 + years working in peritoneal and home hemodialysis, 15+ years of  policy and procedure development and review as chair and co-chair for both in-center and home dialysis, and various other task forces to improve outcomes for patients.  

Valerie Dehline is a Nurse Consultant for hospital and ESRD regulations. Valerie works in the Bureau of Education Services and Technology within the Quality Assurance Division for the State of Wisconsin. Valerie has a master’s degree in nursing and has worked as a nurse for almost 40 years. Valerie has worked with regulatory requirements for over 15 years and has worked in both hospital and clinic settings.

Adrian Amedia currently serves as the RHA Treasurer and is the owner of Independent Dialysis Group, LLC. He has extensive experience with Nephrology and Dialysis billing, payer contracting, EHR integration, dialysis facility operations, access center operations and healthcare business development. Independent Dialysis Group operates 7 clinics in Ohio and Pennsylvania. Providing over 25 years of care ranging from HD, PD, HHD and SNF HHD.

Julie Williams has been a Dialysis Administrator for 35 years working as an Administrator for several small, physician-owned dialysis programs in SW Missouri, NW Arkansas and NE Oklahoma. She was Controller and Area Administrator for Renal Care Group for 5 years and was responsible for regulatory and financial oversight of East Texas Market including outpatient hemodialysis, peritoneal dialysis and acute dialysis programs. She also worked on a due diligence team to review programs for acquisitions. Julie is currently Administrator and part owner with multiple physician groups of 6 independent dialysis programs. She was a Practice manager for a Nephrology group practice for almost 30 years.

Adrian Amedia currently serves as the RHA Treasurer and is the owner of Independent Dialysis Group, LLC. He has extensive experience with Nephrology and Dialysis billing, payer contracting, EHR integration, dialysis facility operations, access center operations and healthcare business development. Independent Dialysis Group operates 7 clinics in Ohio and Pennsylvania. Providing over 25 years of care ranging from HD, PD, HHD and SNF HHD.

Julie Williams has been a Dialysis Administrator for 35 years working as an Administrator for several small, physician-owned dialysis programs in SW Missouri, NW Arkansas and NE Oklahoma. She was Controller and Area Administrator for Renal Care Group for 5 years and was responsible for regulatory and financial oversight of East Texas Market including outpatient hemodialysis, peritoneal dialysis and acute dialysis programs. She also worked on a due diligence team to review programs for acquisitions. Julie is currently Administrator and part owner with multiple physician groups of 6 independent dialysis programs. She was a Practice manager for a Nephrology group practice for almost 30 years.

Danilo Concepcion has been a dialysis practitioner since 1975 and is currently the Operations Manager, Renal Services for Providence St. Joseph Hospital, Orange, CA. Prior to his entering the dialysis field, he was a corpsman in the Navy during the Vietnam era. He is experienced in the clinical, technological, research and administrative areas of dialysis. He is an executive committee member and project committees for numerous dialysis related organizations, and is a prolific national and international speaker and writer and has been published in numerous professional journals and has been a contributing author on several dialysis manuals and APIC Elimination Guide – Guide to the Elimination of Infection in Hemodialysis; a member of the Renal and Disease Detoxification Committee since 2000 for AAMI (Association for the Advancement of Medical Instrumentation) that develops the American standards and recommended practice for dialysis; a member of the American Society of Nephrology/Centers for Disease and Prevention “Nephrologist Transforming Dialysis Safety Project Committee;” NKF’s ECHO project faculty; and, Dialysis Safety Workgroup for CDC Making Dialysis Safer Coalition. He is also on the Editorial Advisory Board for Nephrology News and Issues and currently on the ESRD Network 18 Advisory Committee. He also operates Renal Logistics, LLC, a dialysis consulting firm.

Shannon L. Moore, MS, RD, LD/N serves as President of the Florida Renal Association, bringing over 20 years of experience across renal nutrition, dialysis operations, pharmaceutical sales, and patient advocacy. In her role, she has led initiatives that elevate kidney care across Florida, including the coordination of the annual Kidney Day at the Capitol and support of legislative efforts such as the 2022 Living Organ Donor Protection Act (HB 1099). Shannon is currently National Accounts Director (Outpatient) at CorMedix, overseeing national strategy for DefenCath in the dialysis and access center space. A registered dietitian and long-time champion for the renal community, she is deeply committed to advancing access, education, and outcomes for kidney patients statewide. Shannon also serves on the Board of Directors for the National Kidney Foundation of Florida and continues to advocate for policy change and innovation in kidney care.

Amy Kozsuch, MSN, MBA, is the Chief Executive Officer of Central Florida Kidney Centers, Inc., a nonprofit dialysis organization committed to delivering compassionate, community-based care. With over two decades of leadership experience in nephrology, Amy has held roles spanning clinical operations, strategic development, and health policy. She also serves as a past president board member of the National Kidney Foundation of Florida and the Florida Renal Association, where she advocates for equitable access to kidney care and champions innovation across the continuum of dialysis services. Her work reflects a deep commitment to patient-centered care, operational excellence, and advancing the mission of nonprofit providers in today’s evolving healthcare landscape.

Mr. Ron Watson is Founder and President of Watson Strategies, a full-service healthcare lobbying firm based in Tallahassee. Mr. Watson has over 35 years of experience in Florida political, regulatory, campaign and lobbying endeavors. He previously lobbied for physicians and dentists with the Florida Medical Association (FMA), the Florida Osteopathic Medical Association (FOMA), and the Florida Dental Association (FDA). He was also formerly the Executive Director of the Florida Society of Cannabis Physicians. He is also a founder of MuV by Verano and was Director of Governmental Relations and NW Florida Outreach Coordinator. MuV is one of the Florida licensed medical marijuana treatment centers with 81 locations (MMTC) which Mr. Watson helped form when he spearheaded the passage of the original “Charlotte’s Web / Low-THC Cannabis” bill as well as the passage of SB 8-A, which implements the Constitutional Amendment on medical marijuana. During this time, he has developed excellent relationships with executive, legislative and regulatory leadership throughout Florida government. Mr. Watson has a comprehensive knowledge of laws, rules, budgets and regulations concerning medical, dental, pharmaceutical, tort reform and insurance issues. He also has extensive political involvement with patient advocacy and grassroots organizations, as well as organizing and managing political action committees.<br>

Jason is a corporate healthcare partner with Benesch  who regularly represents a variety of dialysis and nephrology providers, vascular access centers, office-based laboratories, ambulatory surgery centers, physician group practices and other providers in structuring transactions and regulatory matters and responding to governmental investigations.  Jason serves as outside co-counsel for the RPA and ASDIN and also regularly speaks at a variety of industry trade group events in the endovascular arena.  Jason has been recognized as a leading lawyer by Chambers USA since 2019.  He is also a former President of the Illinois Association of Healthcare Attorneys where he also served as a member of its board of directors for many years,

Jake focuses on healthcare law and encompasses a range of regulatory, transactional and corporate matters. His work includes counseling clients with regard to the legal aspects of day-to-day operations, including general corporate matters; anti-kickback and Stark issues; self-referral, corporate practice of medicine and fee-splitting prohibitions; compliance; state regulatory and licensure matters; and HIPAA and health information privacy. Jake regularly represents a variety of dialysis and nephrology providers, vascular access center operators and owners, hospitals, physician group practices, infusion therapy owners and operators, behavior health providers, skilled nursing facilities, healthcare information technology companies and other healthcare providers in structuring mergers and acquisitions, joint ventures, accountable care and capitated care arrangements, syndications and divestitures. Jake was recognized by his peers in the 2025 edition of Best Lawyers: Ones to Watch® in America for his exceptional work in Health Care Law. Earlier in Jake’s career he practiced as a litigator for Chicago-based law firms. He also has served as staff assistant to U.S. Senator Tom Harkin and to the Senate Committee on Health, Education, Labor and Pensions.

Dr. Jeffrey M. Rimmer received his MD from the University of Connecticut Health Center, completed a medical residency at the Rhode Island Hospital, Brown University and and a Nephrology Fellowship at The Robert Larner, M.D. College of Medicine at The University of Vermont. He developed the University of Vermont Medical Center dialysis system over the past forty years where he remains the Senior Medical Director. During this time he was also active in research in areas of dialysis, ckd and hypertension.He aslo wass an educator working with medical students, residents and fellows. With a long interest in improving care in CKD, he received a grant from OneCare Vermont to develop a CKD Navigator program with the goal of addressing the needs of persons with advanced kidney disease. That program continues within the the University of Vermont Health Network.

Haylee Kirschner, LCSW is a facility social worker serving Northeast Pennsylvania with a strong commitment to advancing equity in healthcare access for all. She holds a Bachelor of Social Work from Elizabethtown College and a Master of Social Work from Marywood University. She is a licensed clinical social worker, and a current Doctor of Social Work (DSW) candidate at Kutztown University. Her research centers on access to healthcare, rural poverty, and spatial disparities, with a particular interest in how geography and infrastructure impact service delivery in underserved communities.

Dr. Daniel Landry is a private practice nephrologist working for Kidney Care & Transplant Services of New England, a group composed of 14 nephrologists, transplant/vascular access surgeons and advanced practitioners located in Springfield, MA. They have been involved in the ESCO since its inception in 2017 and now are involved in the Kidney Care First value-based payment model aimed at improving the outcomes of people living with kidney disease. He currently serves as the president of the National Forum of ESRD Networks as well as the chair of the medical review board for ESRD Network 1. He is the division chief and fellowship program director for nephrology at Baystate Medical Center and the medical director for their acute dialysis and critical care nephrology programs. In the outpatient world, he is the medical director of Fresenius outpatient and home dialysis programs in East Springfield, MA. Dr. Landry’s clinical and research interests include population health and value-based care delivery models, as well as efforts to improve the education of our next generation of nephrology physicians and advanced practice providers. 

Donald A. Molony, M.D. is a Regents Distinguished Teaching Professor of the University of Texas System and Professor of Medicine in the Division of Renal Diseases and Hypertension and in the Center for Clinical Research and Evidence-Based Medicine at the University of Texas McGovern Medical School in Houston. He has served as Course-Director for Problem Based Learning and Fundamentals of Clinical Medicine, core medical school courses at UT Houston. He has served as Chair of the Medical School Faculty Senate and Chair of University of Texas System Faculty Advisory Council. He is a member of the UT-Houston Medical School Academy of Master Educators, and The University Of Texas Shine Academy of Health Sciences Education.  He has served on the curriculum committee and chairs the UTHealth Chemical Safety Committee.  He has served as director of Evidence-based Medicine for MHH-TMC and on the Memorial Hermann Hospital System Health Informatics Committee. He is Past-Chair of the ESRD Network 14 Medical Review Board, Past-Chair of the Medical Advisory Council of the Forum of ESRD Networks, and Past-President of the Forum.  He currently serves as Network 14 representative on the Forum Medical Advisory Council.   He has represented the Forum on the Kidney Care Quality Alliance. He has served on the Renal Physicians Association Educational Committee since 2017. Dr. Molony is co-edited with Dr. Jonathan Craig of Adelaide, Australia and Giovanni Strippoli of Bari, Italy of the textbook Evidence-based Nephrology 2nd Edition (Published 2023). He has served as CME Section Editor for the American Journal of Kidney Disease, as an associate editor of Advances in Chronic Kidney Diseases, as section editor of Clinical Nephrology, and as editor of Literature Watch for Dialysis and Transplantation. Dr. Molony’s current research focuses on the influence of environmental toxicants and other factors on the progression of chronic kidney disease and on the application of the principles of evidence-based medicine and epidemiology to the delivery of health care, in particular, how new advances in science and clinical trials can be seamlessly and optimally incorporated into the evidence-based Nephrology practice. He serves as co-PI on a NIH sponsored research project examining the effects of metals including uranium on CKD and cardiovascular disease in a Native-American population. Dr. Molony received his BS in biology from Yale and his MD from the University of California, San Diego. He completed his internship and residency in 1981 in the Department of Internal Medicine at the University of Texas Southwestern Medical School and Parkland Memorial Hospital in Dallas, Texas. His research and clinical fellowships were completed at the University of Texas Southwestern Medical School (1981-1984). He has been a faculty member at the University of Texas McGovern Medical School-Houston since 1984.

Mary Baliker has a degree from the University of Wisconsin in Public Health and Psychology. Her professional work experience over the past 30 years includes innumerable international, national, and state patient centered initiatives. She has worked with many healthcare organizations; including the University of Wisconsin School of Medicine & Public Health, and Long Beach Memorial Hospital, she has served as an organ procurement coordinator, clinical research transplant coordinator, outreach transplant education coordinator, and healthcare administration. Currently she works as a healthcare consultant as well as an inspirational speaker, educating, mentoring, and informing attendees with her stories and personal journey. In addition to Mary’s consulting and volunteer work she has written a book which can be found on Amazon, “Maria Never Gives Up” “Are You Like Me?” she hopes to help other children and their families in their struggle with a health crisis. Mary was diagnosed with kidney disease at the age of 9 and has experienced in-center hemodialysis various times in her life. At 17, she had a kidney transplant from her brother, Doug. Since then, she has had three more transplants, the last of which was in 1999. As a result of this life-long experience, she cherishes her life and possesses a strong interest to help improve healthcare, patient outcomes and quality of life. She is passionate and committed to helping kidney patients. Mary has extensive experience in collaborating with Pharmaceutical Companies, Nonprofits, and Universities. She also participates in technical expert panels led by the Center for Medicare & Medicaid Services and been a peer reviewer for the US Department of Defense medical research programs, and Patient-Centered Outcomes Research Institute. She has published peer reviewed publications and written articles sharing the patient experience. Mary’s diverse background has inspired her to become a fierce healthcare advocate. She serves on: 1. American Association of Nephrology: Kidney Health Initiative (KHI) Board of Directors 2. CJASN Editorial Leadership 3. The National Forum of ESRD Networks: Board of Directors & Kidney Patient Advisory Council Chair 4. Midwest Kidney Network (region 11): Board of Directors & Consumer Committee 5. ESRD National Coordination Center NPFE-LAN Member: (Legacy) 6. Centers for Medicare & Medicaid Services (CMS) Quality Measure Development Plan (MDP)/Quality Measure Index (QMI) (TEP) Technical Expert Panel Chair 7. Centers for Medicare & Medicaid Services (CMS) Development of Quality Measures to Improve Kidney Transplant Access and Post-Transplant Outcomes (TEP) Technical Expert Panel 8. ETCLC ESRD Treatment Choices Learning Collaborative: National Faculty & Patient & Family Representative 9. National Kidney Foundation (NKF): Kidney Advocacy Committee Chair, Public Policy Committee Chair, & Peer Mentor 10. National Kidney Foundation: (Workgroups): Patient Network Data Use and Publication Committee, Transplant Advisory Committee, Spring Clinical Meeting 2025 Planning Committee, and Coalition for Kidney Health 11. UCSF Kidney Project: Patient Advisory Council 12. UW Center for Dialysis Innovation: Patient Advisory Board 13. University of Wisconsin (UW) Transplant: Patient & Family Advisory Committee 14. UW Friends: Board of Directors